Treatment | PH1 | Â | NPP | Â | NSP | Â | PH2 | Â | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
TGx-1336644 | GIZA | Pooled | TGx-1336644 | GIZA | Pooled | TGx-1336644 | GIZA | Pooled | TGx-1336644 | GIZA | Pooled | |
TAL-379 | 70.7a | 71.3a | 71.0a | 134.7a | 176.1a | 155.4a | 2.626a | 2.700a | 2.663a | 77.1ab | 81.7a | 79.4a |
UK Isolate | 73.0a | 61.0ab | 67.0ab | 145.9a | 153.3b | 149.6a | 2.624a | 2.662ab | 2.643a | 82.1ab | 80.3a | 81.2a |
Local | 61.8b | 56.9b | 59.3c | 149.8a | 153.0b | 151.4a | 2.367ab | 2.692a | 2.529a | 86.4a | 75.0a | 80.7a |
Control | 61.2b | 64.0ab | 62.6bc | 115.0b | 102.9c | 108.9b | 2.180b | 2.367b | 2.273b | 69.7b | 64.8b | 67.2b |
Mean | 66.7 | 63.3 | 65.0 | 136.3 | 146.3 | 141.3 | 2.449 | 2.605 | Â | 78.8 | 75.4 | 77.1 |
F value: | ||||||||||||
Inoculation (I) | 7.34** | 4.71** | 8.06*** | 10.09*** | 29.54** | 33.45*** | 8.28** | 3.95* | 10.56*** | 2.77ns | 8.82** | 6.98** |
Genotype (G) | Â | Â | 3.51ns | Â | Â | 7.06* | Â | Â | 8.02** | Â | Â | 1.81ns |
G x I | Â | Â | 3.39* | Â | Â | 9.01*** | Â | Â | 1.38ns | Â | Â | 1.74ns |
LSD | 8.55 | 10.8 | 6.69 | 18.8 | 21.8 | 14.0 | 0.2888 | 0.3084 | 0.206 | 16.58 | 9.9 | 9.40 |
CV (%) | 10.05 | 13.3 | 11.7 | 10.8 | 11.7 | 11.3 | 9.23 | 9.3 | 9.3 | 16.5 | 10.3 | 13.9 |
SEM± | 6.70 | 8.43 | 7.61 | 14.7 | 17.07 | 15.95 | 0.2261 | 0.2414 | 0.2339 | 12.97 | 7.74 | 10.7 |